31. Regional Variations In Alirocumab Dosing Patterns During An Open-Label Extension Study In Patients With Heterozygous Familial Hypercholesterolaemia. (August 2019) Authors: Langslet, G.; Hovingh, G.K.; Guyton, J.R.; Baccara-Dinet, M.T.; Letierce, A.; Manvelian, G.; Farnier, M. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Statins Reduce Hepatic Angptl3 Expression And Secretion, Likely By Interfering With Lxr-Mediated Transcription. (August 2019) Authors: Grefhorst, A.; Reeskamp, L.F.; Huijgen, R.; Hovingh, G.K. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. The effect of long-term low lipoproteins on neurocognitive function. (August 2018) Authors: Verbeek, R.; Boekholdt, S.M.; Luben, R.; Stroes, E.S.G.; Khaw, K.-T.; Hovingh, G.K. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Treatment gaps in paediatric patients with homozygous familial hypercholesterolaemia. (August 2022) Authors: Reijman, M.D.; Tromp, T.R.; Kusters, D.M.; Wiegman, A.; Groothoff, J.W.; Blom, D.J.; Raal, F.J.; Cuchel, M.; Hovingh, G.K. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families. (24th June 2013) Authors: Bochem, A.E.; van Capelleveen, J.C.; Dallinga‐Thie, G.M.; Schimmel, A.W.M.; Motazacker, M.M.; Tietjen, I.; Singaraja, R.R.; Hayden, M.R.; Kastelein, J.J.P.; Stroes, E.S.G.; Hovingh, G.K. Journal: Clinical genetics Issue: Volume 85:Number 5(2014:May) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: A European cross-sectional study. Issue 1 (May 2015) Authors: Koopal, C.; Retterstøl, K.; Sjouke, B.; Hovingh, G.K.; Ros, E.; de Graaf, J.; Dullaart, R.P.F.; Bertolini, S.; Visseren, F.L.J. Journal: Atherosclerosis Issue: Volume 240:Issue 1(2015) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Worldwide perspective on homozygous familial hypercholesterolemia diagnosis, treatment and outcome – results from the HICC registry. (August 2021) Authors: Tromp, T.R.; Hartgers, M.L.; Hovingh, G.K.; Blom, D.J.; Cuchel, M.; Raal, F.J. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗